NZ sharemarket starts week down 0.5%

NZ sharemarket starts week down 0.5%
(Image: Getty)
Graham Skellern
Cancer diagnostic company Pacific Edge slumped 55% after failing to get the backing for continued United States Medicare payments for its Cxbladder tests, and the New Zealand sharemarket joined global moves with a fall.After a sell-down on Wall Street at the weekend, the S&P/NZX 50 Index traded weakly till a late turnaround and closed at 12,827.33, down 68.65 points or 0.53%. Volumes were light, with 30.08 million shares worth $71.1 million changing hands – nearly half of them being Pacific Edge on trade of 13.12 million shares w...

More Markets

F&P Healthcare one step closer to new Karaka campus
Policy

F&P Healthcare one step closer to new Karaka campus

Auckland Council has approved a request to rezone nearly 90ha going to hearings.

Briscoe Group half-year splits analysts
Retail

Briscoe Group half-year splits analysts

Forsyth Barr says the stock is “quality but expensive”.

Spark joins global JV to sweat connectivity
Markets

Spark joins global JV to sweat connectivity

Getting more value from existing networks is now the name of the game.

Former Chubb Life CEO Gail Costa's industry contribution recognised
Markets

Former Chubb Life CEO Gail Costa's industry contribution recognised

Life-insurance luminary Gail Costa cinches top laurel at financial services awards